Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to the Annual General Meeting of shareholders of I.A.R. Systems Group AB (publ)

The shareholders of I.A.R. Systems Group AB (publ) (the “Company” or “IAR Systems”) are hereby invited to attend the Annual General Meeting of shareholders to be held on Wednesday, April 29, 2020 at 6:00 p.m. at Spårvagnshallarna, Birger Jarlsgatan 57 A, Stockholm, Sweden.Notification, etc.Shareholders who wish to participate in the Annual General Meeting (“AGM”) must: – be recorded in the share register maintained by Euroclear Sweden AB not later than Thursday, April 23, 2020, and– provide notification of their intention to participate in the AGM not later than Thursday, April 23,

PowerCell receives order for PowerCell S3 from Bosch at a total value of MSEK 11.5

PowerCell Sweden AB has received an order for PowerCell S3 fuel cell stacks from Bosch at a total value of approximately MSEK 11.5 (1,047,900 Euro). The order will have a positive financial impact during the first quarter 2020.The order comprises several PowerCell S3 fuel cell stacks to be delivered to Bosch within the framework of the joint development and licensing agreement. In April last year German Robert Bosch GmbH and PowerCell Sweden signed an agreement regarding the development, production and sale of the PowerCell S3 fuel cell stack for the automotive segment. The agreement

Withdrawal of Dividend Proposal and Unchanged Board fees

The Saab Board of Directors confirms its assessment of the company’s dividend capacity for the financial year 2019 but due to the uncertainty the COVID-19 outbreak creates in the surrounding world, the Board has decided to withdraw its dividend proposal to the Annual General Meeting. When the situation can be better analysed, the Board can assess the possibility of a new dividend proposal for 2019.Saab’s Annual General Meeting is to take place on April 1, 2020. In its dividend motivation, the Saab Board of Directors assesses the company’s 2019 dividend capacity to not affect Saab’s ability

Catena’s Annual Report for 2019 has been published

30 March 2020, 08:30 a.m. CETCatena’s Annual Report for 2019 has now been published on the company´s website, www.catenafastigheter.se/investerare/rapporter/. The Annual General Meeting will be held in Stockholm on 29 April 2020. Printed copies of the Annual Report will be available on order in April by email info@catenafastigheter.se. Both the Swedish original and an English translation of the Annual Report are available from today on Catena’s website.   For further information, please contactBenny Thögersen, CEO                                           Tel. +46 706-60 83

CircleK extends relationship with Zalaris for European Payroll and HR services

Zalaris ASA announced the renewal of its agreement with CircleK to deliver European Managed Payroll and HR services for another five-year term.The new agreement includes the provision of managed payroll and HR services for CircleK’s more than 14,000 employees in Norway, Sweden, Denmark, Estonia, Latvia, Lithuania, Poland and Ireland. Services will continue to be powered by Zalaris’ proven Multi-Country Cloud solution for payroll, time, travel expenses and digital personnel archive with portal and mobile self service for HR professionals, managers and employees.  As part of the agreement,

Imfinzi approved in the US for extensive-stage small cell lung cancer

30 March 2020 07:00 BST  Imfinzi approved in the US for extensive-stage small cell lung cancer  Only PD-1/PD-L1 immunotherapy to demonstrate a significant survival benefit in combination with etoposide and a choice of carboplatin or cisplatin chemotherapy  AstraZeneca's Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide).  The approval by the Food and

Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease

30 March 2020 07:00 BST Farxiga Phase III DAPA-CKD trial will be stopped early afteroverwhelming efficacy in patients with chronic kidney disease   Farxiga is the first SGLT2 inhibitor to show meaningful benefit in patients with chronic kidney disease in a trial including both type-2 diabetics and non-diabetics The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for Farxiga (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped early following a recommendation from an independent Data Monitoring

Notice of Annual General Meeting in LeoVegas AB (publ)

The shareholders of LeoVegas AB (publ), reg. no. 556830-4033, (the ”Company”), are hereby convened to an annual general meeting to be held on Friday 8 May 2020, at 12.30 p.m. at the cinema Grand’s premises on Sveavägen 45 in Stockholm. The doors to the meeting will open at 12.00. Due to the development of covid-19 the goal is that the Annual General Meeting shall be swift and effective to minimize spread of disease. As part of this no food will be served in connection with the meeting. Shareholders who are sick, recently travelled in a risk zone or are part of a risk group should not

Isofol announces its intention to carry out a fully guaranteed preferential rights issue of approximately SEK 150 million and a potential over-allotment option of up to approximately SEK 30 million

GOTHENBURG, Sweden, March 30, 2020 - Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that the Board has the intention to carry out a rights issue of approximately SEK 150 million with preferential rights for the Company’s existing shareholders (the “Rights Issue”). An extraordinary general meeting will be held around May 5, 2020 (the “EGM”) where the EGM is proposed to resolve to authorize the Board of Directors to resolve on the Rights Issue and the terms thereof. The EGM is also proposed to resolve to authorize the Board of Directors to resolve

Part 1 of the MATINS Phase I/II Study Completed

Faron Pharmaceuticals Oy                      ("Faron" or the "Company") Completion of Part 1 dose finding stage of the MATINS Phase I/II Study Study data monitoring committee recommends rapid expansion of study into new tumour types following promising results Company announcement, 30 March 2020 at 9.00 AM (EET)Inside information TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces positive feedback from the MATINS study data monitoring committee ("DMC") following a comprehensive review

Postpone the Thailand Travel Mart Plus 2020 (TTM+ 2020)

 Due to escalating health concerns related to the spread of the coronavirus disease 2019 (COVID-19) in Thailand and other countries, the Tourism Authority of Thailand (TAT) has decided to postpone the Thailand Travel Mart Plus 2020 (TTM+ 2020) in Phuket, Thailand scheduled 1-3 June 2020. New dates of the event will be advised when they are set. The TTM+ 2020 venue shall remain in Phuket.This decision was made after extensive and careful consideration of the current situation and outlook alongside our commitment to cooperate with government efforts to mitigate the spread of COVID-

Irisity AB (publ) provides an update on the current situation with respect of COVID-19

In view of the general uncertainty and measures put in place by authorities around the world to reduce the spread of COVID-19 and their impact on the global economy, Irisity is closely monitoring developments and is prepared to take measures to reduce the risk of the company's continued operation and expansion being long-term affected. Travel restrictions, cancellations of meetings and general difficulties in conducting the sales process may affect demand for the company's products and services. The financial consequences are still difficult to estimate, but the company will continuously

Fiskars is planning to temporarily close its stores in Finland, initiates employee consultations

Fiskars CorporationPress releaseMarch 30, 2020 at 09:00 EEST Fiskars Corporation is planning to temporarily close its stores in Finland, initiates employee consultationsThe coronavirus outbreak impacts people’s everyday and has a negative impact on consumer demand in Fiskars key markets. The health and wellbeing of employees and customers are a key priority for the company. Fiskars Group has made the decision to temporarily close its stores in Finland. Webstores in Finland remain open. Fiskars will begin employee consultations on temporary layoffs due to production and financial

Notice of the annual general meeting of Cabonline Group Holding AB (publ)

Shareholders of Cabonline Group Holding AB (publ), reg. no 559002-7156, are hereby invited to attend the annual general meeting, to be held on Thursday, 7 May 2020 at 09:00 CET at Cabonline’s premises at Kungsgatan 44 in Stockholm.Right to attend Those wishing to attend the meeting must be entered as shareholders in the share register kept by the Swedish central securities depository Euroclear Sweden on Wednesday, April 29, 2020 and give notice of attendance to the Company no later than on Wednesday 29 April 2020.  Notice of attendance Notice of attendance can be given in

Sedana Medical sees increased demand and keeps time schedule

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company sees increased demand for AnaConDa as a result of the Covid-19 pandemic and so far, has had no significant supply chain disruptions. Sedana Medical forecasts a sales increase of about 50 percent for the first quarter of 2020 and about 100 percent for the month of March, compared to the same periods last year. Due to the Covid-19 pandemic Sedana Medical sees a slight risk of delay of the compilation of the IsoConDa study until the beginning of the third quarter of 2020. However, this would not necessarily mean

Publication of Catena Media’s Annual Report 2019

Catena Media plc (Nasdaq Stockholm: CTM)Catena Media plc has today published its Annual Report for 2019 on Catena Media's website, https://www.catenamedia.com/investors/reports/annual-reports/ The report is available in a pdf format for downloading and in English only.“The first half of the year was challenging with regulations in several markets. The second half of 2019 we started a positive trend. Revenue increased, and we slowed our cost development.”    Per Hellberg, CEO  For further information, please contact:   Per Hellberg, CEO, Catena Media plcPhone: +46 709 10 74

Gene expression data from new analysis method supports that a larger proportion of patients will benefit from arfolitixorin

GOTHENBURG, Sweden, March 30, 2020 - Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that new gene expression data based on a validated method from TATAA Biocenter AB, which is significantly more sensitive than the pre-commercial method, shows that a larger proportion of patients, i.e. those with low ABCC3 expression, could have significant better effect of arfolitixorin than currently used prodrugs (leucovorin) on PFS and ultimately on overall survival.The data from the optimized gene expression method validated by TATAA Biocenter AB, compared

Torbjørn Wist to leave his position as CFO of SAS AB (publ)

SAS AB (publ) (SAS) today announces that CFO Torbjørn Wist has given notice that he will leave the company in September 2020 to take on the role as CFO of Wallenius Wilhelmsen. SAS has initiated the process of finding his successor and Wist will continue in his current role during his notice period, or until a successor is in place.- I would like to thank Torbjørn for his contribution over the last few years. Although I regret Torbjørn is leaving I do understand and respect his decision. We will immediately start the process to recruit a new CFO, says Rickard Gustafson. - This has not

Eniro's parent company files for company restructuring. The operating subsidiaries are not covered by the company restructuring.

The holding company Eniro AB (publ), which is the parent company of Eniro Group, is filing an application for company restructuring. The application covers only the parent Company, a holding company with five employees only, and which do not conduct any operational business apart from  group-wide functions. The operating business carried out in the Eniro subsidiaries, including Eniro Sverige AB, Eniro 118 118 AB, Eniro Treasury AB, Eniro Sverige Försäljning AB, Gule Sider AS, Krak A/S, Oy Eniro Finland Ab, etc., continue to run and develop their business as partner to the small and

Hoist Finance Launches New Sustainability Strategy

Hoist Finance, a trusted debt resolution partner to individuals, companies and banks, today announces its new sustainability strategy, which outlines the company’s Environmental, Social and Governance (ESG) goals and indicators. The sustainability strategy and extensive reporting puts Hoist Finance as a front runner in the debt management industry. Through a bottom-up process, integrating feedback and insight from employees throughout the whole organisation, Hoist Finance developed a sustainability strategy focused on four core pillars: contributing to an inclusive financial ecosystem,

Hoist Finance's Annual Report 2019 Published

Hoist Finance’s annual report 2019 and the Pillar 3 report are now published on our website. The annual report is available both in an online version  and as a downloadable PDF document. 2019 was a year of execution, working to deliver on the agenda to become the most effective and efficient company in the industry. Some of our strategic changes during the year included the site consolidation in France and the outsourcing of the entire IT infrastructure. The ambition to become a digital leader in the industry continued with self-service platforms in

Change in the KONE Executive Board – Ken Schmid appointed Executive Vice President, KONE Americas

KONE Corporation, stock exchange release, March 30, 2020 at 8:30 a.m. EEST Change in the KONE Executive Board – Ken Schmid appointed Executive Vice President, KONE Americas   Ken Schmid (Master of Business Administration), has been appointed Executive Vice President of KONE Americas as of April 1, 2020. He will continue as a member of KONE Executive Board and report to Henrik Ehrnrooth, President and CEO, KONE Corporation. He will be based in Lisle, IL, United States. In addition to his previous role as Senior Vice President, Finance for KONE Americas, Ken has served as interim

Fellow Finance market share continues to grow and exceeded 60% of the total market in 2019

FELLOW FINANCE PLC PRESS RELEASE 30.3.2020 AT 8:00 AMFellow Finance market share of Finnish peer-to-peer lending and crowdfunding markets increased by approximately 4,5 percentage points to total of 60,5% compared to the previous year. According to the Bank of Finland statistics released on 26th of March 2020, the total funding volume of intermediated loans to Finnish consumers and businesses through the peer-to-peer and crowdfunding platforms was about EUR 330 million in 2019. The peer-to-peer and crowdfunding markets have continued to grow strongly in Finland, particularly the loan-based

There are no items matching the current filter
There are no more items matching the current filter
Back to top